Get started
GLAXO SMITH KLINEGLAXO SMITH KLINEGLAXO SMITH KLINE

GLAXO SMITH KLINE

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BIOC chart


Full chart

BIOC upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.59 B‬ EGP
Dividend yield (indicated)
1.74%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪2.43 M‬
Beta (1Y)
0.09

About GLAXO SMITH KLINE


Sector
Health Technology
Headquarters
Cairo
Founded
1981
Website
gsk.com
ISIN
EGS38171C012
FIGI
BBG000C181F6
GlaxoSmithKline (Egypt) engages in the pharmaceutical and healthcare business. Its business operations are carried out through the production, packaging, marketing, sale, and distribution of medicines and other pharmaceutical products. The company was founded on January 14, 1981 and is headquartered in Cairo, Egypt.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BIOC news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOC is 43.010 EGP — it has decreased by −0.21% in the past 24 hours. Watch GLAXO SMITH KLINE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange GLAXO SMITH KLINE stocks are traded under the ticker BIOC.
BIOC stock has risen by 5.73% compared to the previous week, the month change is a 22.08% rise, over the last year GLAXO SMITH KLINE has showed a 33.61% increase.
BIOC reached its all-time high on Feb 21, 2024 with the price of 47.500 EGP, and its all-time low was 5.770 EGP and was reached on Mar 18, 2020. View more price dynamics on BIOC chart.
See other stocks reaching their highest and lowest prices.
BIOC stock is 7.93% volatile and has beta coefficient of 0.09. Track GLAXO SMITH KLINE stock price on the chart and check out the list of the most volatile stocks — is GLAXO SMITH KLINE there?
Today GLAXO SMITH KLINE has the market capitalization of ‪3.59 B‬, it has decreased by −3.28% over the last week.
Yes, you can track GLAXO SMITH KLINE financials in yearly and quarterly reports right on TradingView.
GLAXO SMITH KLINE is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOC net income for the last quarter is ‪−8.99 M‬ EGP, while the quarter before that showed ‪27.16 M‬ EGP of net income which accounts for −133.11% change. Track more GLAXO SMITH KLINE financial stats to get the full picture.
Yes, BIOC dividends are paid annually. The last dividend per share was 0.75 EGP. As of today, Dividend Yield (TTM)% is 1.74%. Tracking GLAXO SMITH KLINE dividends might help you take more informed decisions.
Like other stocks, BIOC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLAXO SMITH KLINE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLAXO SMITH KLINE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLAXO SMITH KLINE stock shows the strong buy signal. See more of GLAXO SMITH KLINE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.